Top

World Journal of Urology

Published in:

Open Access 01-02-2015 | Topic Paper

Kidney stone analysis: “Give me your stone, I will tell you who you are!”

Authors: Jonathan Cloutier, Luca Villa, Olivier Traxer, Michel Daudon

Published in: World Journal of Urology | Issue 2/2015

Abstract

Introduction

Stone analysis is an important part in the evaluation of patients having stone disease. This could orientate the physician toward particular etiologies.

Material and methods

Chemical and physical methods are both used for analysis. Unfortunately, chemical methods often are inadequate to analyze accurately urinary calculi and could fail to detect some elements into the stone. Physical methods, in counterpart, are becoming more and more used in high-volume laboratories. The present manuscript will provide a review on analytic methods, and review all the information that should be included into an appropriate morpho-constitutional analysis.

Conclusion

This report can supply an excellent summarization of the stone morphology and give the opportunity to find specific metabolic disorders and different lithogenic process into the same stone. Here, specific chemical types with their different crystalline phases are shown in connection with their different etiologies involved.

Soucie JM, Coates RJ, McClellan W, Austin H, Thun M (1996) Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol 143:487–495PubMedCrossRef

Ekane S, Wildschutz T, Simon J, Schulman CC (1997) Lithiase urinaire : épidémiologie et physiopathologie. Acta Urol Belg 65:1–8PubMed

Trinchieri A, Coppi F, Montanari E, Del Nero A, Zanetti G, Pisani E (2000) Increase in the prevalence of symptomatic upper urinary tract stones during the last ten years. Eur Urol 37:23–25PubMedCrossRef

Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P (2003) Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs 2000. Eur Urol 44:709–713PubMedCrossRef

Lee YH, Huang WC, Tsai JY, Lu CM, Chen WC, Lee MH et al (2002) Epidemiological studies on the prevalence of upper urinary calculi in Taiwan. Urol Int 68:172–177PubMedCrossRef

Robertson WG, Peacock M (1982) The pattern of urinary stone disease in Leeds and in the United Kingdom in relation to animal protein intake during the period 1960–1980. Urol Int 37:394–399PubMedCrossRef

Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A (2002) Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 346(2):77–84PubMedCrossRef

Taylor EN, Curhan GC (2008) Fructose consumption and the risk of kidney stones. Kidney Int 73:207–212PubMedCrossRef

Daudon M, Jungers P (2012) Stone composition and morphology: a window on etiology. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 113–140CrossRef

10.

Simmonds HA (1986) 2,8-dihydroxyadenine lithiasis. Clin Chim Acta 160:103–108PubMedCrossRef

11.

Ceballos-Picot I, Perignon JL, Hamet M et al (1992) 2,8-dihydroxyadenine urolithiasis, an underdiagnosed disease. Lancet 339:1050–1051PubMedCrossRef

12.

Bollée G, Harambat J, Bensman A, Knebelmann B, Daudon M, Céballos-Picot I (2012) Adenine phosphoribosyltransferase deficiency. Clin J Am Soc Nephrol 7(9):1521–1527PubMedCrossRef

13.

Daudon M, Estépa L, Viard JP, Joly D, Jungers P (1997) Urinary stones in HIV-1-positive patients treated with indinavir. Lancet 349:1294–1295PubMedCrossRef

14.

Daudon M, Jungers P (2004) Drug-induced renal calculi: epidemiology, prevention and management. Drugs 64:245–275PubMedCrossRef

15.

Couzigou C, Daudon M, Meynard JL et al (2007) Urolithiasis in HIVpositive patients treated with atazanavir. Clin Infect Dis 45:e105–e108PubMedCrossRef

16.

Daudon M, Réveillaud RJ (1984) Whewellite and weddellite: toward different etiopathogenesis. Interest of the morphological typing of the stones. Néphrologie 5:195–201 (in French)PubMed

17.

Maurice-Estepa L, Levillain P, Lacour B, Daudon M (1999) Crystalline phase differentiation in urinary calcium phosphate and magnesium phosphate calculi. Scand J Urol Nephrol 33:299–305PubMedCrossRef

18.

Méria P, Hadjadj H, Jungers P, Daudon M, Members of the Urolithiasis Committee of the French Urological Association (2010) Stone formation and pregnancy: pathophysiological insights gained from morphoconstitutional stone analysis. J Urol 183(4):1412–1416PubMedCrossRef

19.

Daudon M (2005) Épidémiologie actuelle de la lithiase rénale en France. Ann Urol 39:209–231CrossRef

20.

Daudon M, Bader CA, Jungers P (1993) Urinary calculi: review of classification methods and correlations with etiology. Scanning Microsc 7:1081–1106PubMed

21.

Asplin JR, Lingeman J, Kahnoski R, Mardis H, Parks JH, Coe FL (1998) Metabolic urinary correlates of calcium oxalate dihydrate in renal stones. J Urol 159:664–668PubMedCrossRef

22.

Hesse A, Kruse R, Geilenkeuser WJ, Schmidt M (2005) Quality control in urinary stone analysis: results of 44 ring trials (1980–2001). Clin Chem Lab Med 43:298–303PubMedCrossRef

23.

Bastian PJ, Lorken M, Euler H, Lummen G, Bastian HP (2008) Results of the evaluation of 85,337 urinary stone analyses. Aktuelle Urol 39:298–304PubMedCrossRef

24.

Estepa L, Daudon M (1997) Contribution of fourier transform infrared spectroscopy to the identification of urinary stones and kidney crystal deposits. Biospectroscopy 3:347–369CrossRef

25.

Hidalgo A, Santos M, Carmina P, Garcia-Ramos JV, Bellanato J, Cifuentes Delatte L (1983) Analisis de calculos urinarios por espectroscopia infraroja y Raman. Instituto de Optica (Daza de Valdes) C.S.I.C, Madrid

26.

Nguyen Quy D, Daudon M (1997) Infrared and Raman spectra of calculi. Elsevier, Paris

27.

Marickar YM, Lekshmi PR, Varma L, Koshy P (2009) EDAX versus FTIR in mixed stones. Urol Res 37(5):271–276CrossRef

28.

Sharma RN, Shah I, Gupta S, Sharma P, Beigh AA (1989) Thermogravimetric analysis of urinary stones. Br J Urol 64:564–566PubMedCrossRef

29.

Lee TT, Elkoushy MA, Andonian S (2014) Are stone analysis results different with repeated sampling? Can Urol Assoc J 8(5–6):E317–E322PubMedCentralPubMed

30.

Daudon M, Réveillaud RJ, Normand M, Petit C, Jungers P (1987) Piridoxilate-induced calcium oxalate calculi: a new drug-induced metabolic nephrolithiasis. J Urol 138:258–261PubMed

31.

Evan AP, Lingeman JE, Coe FL et al (2003) Randall’s plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111:607–616PubMedCentralPubMedCrossRef

32.

Daudon M, Traxer O, Jungers P, Bazin D. Stone morphology suggestive of Randall’s plaque. In Evan AP, Lingeman JE, Williams JC Jr (eds) Renal stone disease. American Institute of physics conference proceedings, Melville, New York 2007, vol 900, pp. 26–34

33.

Matlaga BR, Coe FL, Evan AP, Lingeman JE (2007) The role of Randall’s plaques in the pathogenesis of calcium stones. J Urol 177:31–38PubMedCrossRef

34.

Daudon M, Traxer O, Williams JC, Bazin DC (2011) Randall’s plaques. In: Rao PN, Preminger GM, Kavanagh JP (eds) Urinary tract stone disease. Springer, London, pp 103–112

35.

Cifuentes Delatte L, Minon-Cifuentes J, Medina JA (1987) New studies on papillary calculi. J Urol 137:1024–1029PubMed

36.

Grases F, Costa-Bauza A, Ramis M, Montesinos V, Conte A (2002) Simple classification of renal calculi closely related to their micromorphology and etiology. Clin Chim Acta 322:29–36PubMedCrossRef

37.

Low RK, Stoller ML (1997) Endoscopic mapping of renal papillae for Randall’s plaques in patients with urinary stone disease. J Urol 158:2062–2064PubMedCrossRef

38.

Daudon M, Jungers P (2004) Clinical value of crystalluria and quantitative morpho-constitutional analysis of urinary calculi. Nephron Physiol 98:31–36CrossRef

39.

Daudon M, Labrunie M, Hennequin C, Lacour B, Jungers P (1997) Relative influence of calcium and oxalate urine concentration on the risk of calcium oxalate crystallization. In: Jungers P, Daudon M (eds) Renal stone disease. Crystallization process, pathophysiology, metabolic disorders and prevention. Elsevier, Paris, pp 72–73

40.

Daudon M, Jungers P, Bazin D (2008) Peculiar morphology of stones in primary hyperoxaluria. N Engl J Med 359(1):100–102PubMedCrossRef

41.

Daudon M, Jungers P, Bazin D. Stone morphology: implication for pathogenesis. In: Evan AP, Lingeman JE, McAteer JA and Williams JC Jr (eds), Renal stone disease 2, American Institute of physics conference proceedings, Melville, New York 2008, vol 1049, pp. 199–215

42.

Daudon M, Réveillaud RJ, Jungers P (1985) Piridoxilate-associated calcium oxalate urinary calculi: a new metabolic drug-induced nephrolithiasis. Lancet 8441:1338CrossRef

43.

Miller NL, Williams JC Jr, Evan AP et al (2009) In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall’s plaque. BJU Int 105:242–245PubMedCentralPubMedCrossRef

44.

Gault MH, Paul MD, Longerich L (1990) Comparison of urinary tract infection in calcium oxalate and calcium phosphate stone formers. Nephron 55:408–413PubMedCrossRef

45.

Daudon M, Bouzidi H, Bazin D (2010) Composition and morphology of phosphate stones and their relation with etiology. Urol Res 38:459–467PubMedCrossRef

46.

Carpentier X, Daudon M, Traxer O et al (2009) Relationships between carbonation rate of carbapatite and morphologic characteristics of calcium phosphate stones and etiology. Urology 73(5):968–975PubMedCrossRef

47.

Bouzidi H, de Brauwere D, Daudon M (2011) Does urinary stone composition and morphology help for prediction of primary hyperparathyroidism? Nephrol Dial Transplant 26:565–572PubMedCrossRef

48.

Pak CY, Nicar MJ, Peterson R et al (1981) A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism. J Clin Endocrinol Metab 53:536–542PubMedCrossRef

49.

Parks JH, Coe FL, Evan AP et al (2009) Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int 103:670–678PubMedCrossRef

50.

Osther PJS (2012) Epidemiology of kidney stones in the European Union. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 3–12CrossRef

51.

Ganesamoni R, Singh SK (2012) Epidemiology of stone disease in Northern India. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 39–46CrossRef

52.

Rodgers A (2012) Epîdemiology: South-Africa and sub-Saharan Africa. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 67–71CrossRef

53.

Korkes F, Schor N, Pfeferman Heilberg I (2012) Epidemiology of stone disease in South America. In: Talati JJ, Tiselius HG, Albala DM, Ye Z (eds) Urolithiasis: basic science and clinical practice. Springer, London, pp 61–66CrossRef

54.

Danpure CJ, Jennings PR, Watts RW (1987) Enzymological diagnosis of primary hyperoxaluria type 1 by measurement of hepatic alanine: glyoxylate aminotransferase activity. Lancet 1:289–291PubMedCrossRef

55.

Cochat P, Hulton SA, Acquaviva C et al (2012) Primary hyperoxaluria Type 1: indications for screening and guidance for diagnosis and treatment. Nephrol Dial Transplant 27:1729–1736PubMedCrossRef

56.

Rumsby G, Sharma A, Cregeen DP, Solomon LR (2001) Primary hyperoxaluria type 2 without L-glycericaciduria: is the disease under-diagnosed? Nephrol Dial Transplant 16:1697–1699PubMedCrossRef

57.

Riedel TJ, Johnson LC, Knight J, Hantgan RR, Holmes RP, Todd Lowther W. Structural and Biochemical Studies of Human 4-hydroxy-2-oxoglutarate Aldolase: Implications for Hydroxyproline Metabolism in Primary Hyperoxaluria. Plos One 2011; 6 (10):1–15, e26021

58.

Monico CG, Rossetti S, Belostotsky R et al (2011) Primary hyperoxaluria type III gene HOGA1 (formerly DHDPSL) as a possible risk factor for idiopathic calcium oxalate urolithiasis. Clin J Am Soc Nephrol 6:2289–2295PubMedCentralPubMedCrossRef

59.

Dick WH, Lingeman JE, Preminger GM, Smith LH, Wilson DM, Shirrell WL (1990) Laxative abuse as a cause for ammonium urate renal calculi. J Urol 143:244–247PubMed

60.

Kato Y, Hou K, Saga Y, Yamaguchi S, Yachiku S, Kawakami N (2004) Ammonium acid urate stone due to laxative abuse: a case report. Hinyokika Kiyo 50:799–803 (in Japanese)PubMed

Title: Kidney stone analysis: “Give me your stone, I will tell you who you are!”
Authors: Jonathan Cloutier
Luca Villa
Olivier Traxer
Michel Daudon
Publication date: 01-02-2015
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 2/2015
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-014-1444-9

At a glance: The STEP trials

Springer Medicine

Kidney stone analysis: “Give me your stone, I will tell you who you are!”

Abstract

Introduction

Material and methods

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Material and methods

Conclusion

Please log in to get access to this content

Other articles of this Issue 2/2015

Metabolic disorders: stones as first clinical manifestation of significant diseases

Kidney stones and imaging: What can your radiologist do for you?

WJU special edition: surgical and medical management of stones

Urinary bladder mucosal responses to ischemia

Ureteroscopy and laser lithotripsy: technologic advancements

CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers